Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOTUS: Ustekinumab in Chinese Patients With Plaque Psoriasis
NCT01008995Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2009
- Primary completion
- Jul 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of ustekinumab in plaque psoriasis, sponsored by Janssen Pharmaceutical. Started Oct 2009; status: completed.
02
Drugs
ustekinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01008995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01008995.